Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ARE logo ARE
Upturn stock ratingUpturn stock rating
ARE logo

Alexandria Real Estate Equities Inc (ARE)

Upturn stock ratingUpturn stock rating
$72.64
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/16/2025: ARE (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

13 Analysts rated it

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

Year Target Price $97.31

Year Target Price $97.31

Analyst’s Price TargetsFor last 52 week
$97.31Target price
Low$66.16
Current$72.64
high$123

Analysis of Past Performance

Type Stock
Historic Profit -23.93%
Avg. Invested days 21
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/16/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 12.69B USD
Price to earnings Ratio 96.54
1Y Target Price 97.31
Price to earnings Ratio 96.54
1Y Target Price 97.31
Volume (30-day avg) 13
Beta 1.27
52 Weeks Range 66.16 - 123.00
Updated Date 06/30/2025
52 Weeks Range 66.16 - 123.00
Updated Date 06/30/2025
Dividends yield (FY) 7.20%
Basic EPS (TTM) 0.76

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 4.61%
Operating Margin (TTM) 20.92%

Management Effectiveness

Return on Assets (TTM) 1.3%
Return on Equity (TTM) 1.48%

Valuation

Trailing PE 96.54
Forward PE 16.69
Enterprise Value 25678009685
Price to Sales(TTM) 4.08
Enterprise Value 25678009685
Price to Sales(TTM) 4.08
Enterprise Value to Revenue 8.45
Enterprise Value to EBITDA 14.4
Shares Outstanding 172988992
Shares Floating 154108868
Shares Outstanding 172988992
Shares Floating 154108868
Percent Insiders 0.99
Percent Institutions 97.92

Analyst Ratings

Rating 4
Target Price 97.31
Buy 1
Strong Buy 3
Buy 1
Strong Buy 3
Hold 9
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Alexandria Real Estate Equities Inc

stock logo

Company Overview

overview logo History and Background

Alexandria Real Estate Equities, Inc. was founded in 1994. It pioneered the life science real estate niche, focusing on clustering premier science and technology campuses. Over time, it has evolved into a leading REIT for the life science, agtech, and technology industries, expanding its geographic footprint and service offerings.

business area logo Core Business Areas

  • Leasing: Leasing of life science, agtech, and technology properties to tenants.
  • Development: Development and redevelopment of laboratory and office space.
  • Property Management: Management of properties.

leadership logo Leadership and Structure

The company is led by Joel S. Marcus, Executive Chairman and Founder. The organizational structure consists of various departments, including real estate operations, development, finance, and legal.

Top Products and Market Share

overview logo Key Offerings

  • Lab Space: Provision of high-quality lab space customized to tenant needs. Market share information is not publicly available in aggregate form, but Alexandria is a leading provider. Competitors include Boston Properties and BioMed Realty Trust (private).
  • Office Space: Provision of office space catering to life science, agtech, and technology companies. Market share information is not publicly available in aggregate form, but Alexandria is a leading provider. Competitors include Boston Properties and BioMed Realty Trust (private).
  • Agtech Facilities: Specialized facilities for agricultural technology companies. Market share information is not publicly available in aggregate form, but Alexandria is a leading provider. Competitors include Boston Properties and BioMed Realty Trust (private).

Market Dynamics

industry overview logo Industry Overview

The life science real estate industry is driven by strong demand for research and development space, fueled by funding for biotechnology and pharmaceutical companies. The agtech and tech real estate segments are also undergoing growth and new innovations.

Positioning

Alexandria is a market leader specializing in life science, agtech, and technology real estate. Its competitive advantages include its deep industry expertise, long-term tenant relationships, and strategic locations.

Total Addressable Market (TAM)

The TAM for life science, agtech, and tech real estate is substantial and growing. Alexandria is well positioned to capture a significant portion of this market due to its specialized focus and premier portfolio. Total TAM estimates range from $100B to $150B based on market analysis and growth projections.

Upturn SWOT Analysis

Strengths

  • Specialized expertise in life science, agtech, and tech real estate
  • High-quality portfolio of properties
  • Strong tenant relationships
  • Strategic locations in key innovation clusters
  • Experienced management team

Weaknesses

  • High concentration in specific geographic areas
  • Sensitivity to fluctuations in research and development funding
  • Exposure to economic downturns affecting tenant companies
  • Capital intensive nature of real estate development
  • Occupancy rates can fluctuate

Opportunities

  • Expansion into new geographic markets
  • Development of new types of specialized facilities
  • Strategic partnerships with life science, agtech, and tech companies
  • Growing demand for lab and office space
  • Increasing government funding for research and development

Threats

  • Economic downturns affecting tenant companies
  • Increased competition from other REITs and developers
  • Changes in government regulations affecting the life science, agtech, and tech industries
  • Rising interest rates increasing borrowing costs
  • Technological obsolescence of facilities

Competitors and Market Share

competitor logo Key Competitors

  • BXP
  • ARE
  • SPG

Competitive Landscape

Alexandria's competitive advantages include its specialized focus, high-quality portfolio, and strategic locations. However, it faces competition from larger, more diversified REITs.

Major Acquisitions

Serra Mesa Properties

  • Year: 2021
  • Acquisition Price (USD millions): 165
  • Strategic Rationale: Expanding presence in San Diego, a key life science cluster.

Growth Trajectory and Initiatives

Historical Growth: Alexandria has experienced significant growth in revenue, net income, and asset value over the past decade, driven by its focus on life science, agtech, and technology real estate.

Future Projections: Analysts expect continued growth in the life science, agtech, and tech industries, which should drive demand for Alexandria's properties. Future projections should be updated with the lastest analyst reporting.

Recent Initiatives: Recent initiatives include the expansion of its portfolio through development and acquisitions, as well as investments in innovation and sustainability.

Summary

Alexandria Real Estate Equities is a strong REIT specializing in life science and technology real estate. Its focus on high-growth sectors and strategic locations drives its performance. However, it faces risks related to economic downturns and competition. The company's dividend and future growth prospects make it a compelling investment option.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Alexandria Real Estate Equities Inc. Investor Relations
  • SEC Filings
  • Financial News Articles
  • Analyst Reports

Disclaimers:

The data provided is for informational purposes only and should not be considered financial advice. Market share data may be estimates based on available information.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Alexandria Real Estate Equities Inc

Exchange NYSE
Headquaters Pasadena, CA, United States
IPO Launch date 1997-05-27
CEO & Chief Investment Officer Mr. Peter M. Moglia
Sector Real Estate
Industry REIT - Office
Full time employees 552
Full time employees 552

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Megacampus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of March 31, 2025, Alexandria has a total market capitalization of $28.8 billion and an asset base in North America that includes 39.6 million RSF of operating properties and 4.0 million RSF of Class A/A+ properties undergoing construction. Alexandria has a longstanding and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Megacampus environments that enhance our tenants' ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.